Suppr超能文献

与局部免疫细胞溶解活性相关的肿瘤的分子和遗传特性。

Molecular and genetic properties of tumors associated with local immune cytolytic activity.

作者信息

Rooney Michael S, Shukla Sachet A, Wu Catherine J, Getz Gad, Hacohen Nir

机构信息

The Broad Institute, Cambridge, MA 02142, USA; Harvard/MIT Division of Health Sciences and Technology, Cambridge, MA 02141, USA.

The Broad Institute, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

出版信息

Cell. 2015 Jan 15;160(1-2):48-61. doi: 10.1016/j.cell.2014.12.033.

Abstract

How the genomic landscape of a tumor shapes and is shaped by anti-tumor immunity has not been systematically explored. Using large-scale genomic data sets of solid tissue tumor biopsies, we quantified the cytolytic activity of the local immune infiltrate and identified associated properties across 18 tumor types. The number of predicted MHC Class I-associated neoantigens was correlated with cytolytic activity and was lower than expected in colorectal and other tumors, suggesting immune-mediated elimination. We identified recurrently mutated genes that showed positive association with cytolytic activity, including beta-2-microglobulin (B2M), HLA-A, -B and -C and Caspase 8 (CASP8), highlighting loss of antigen presentation and blockade of extrinsic apoptosis as key strategies of resistance to cytolytic activity. Genetic amplifications were also associated with high cytolytic activity, including immunosuppressive factors such as PDL1/2 and ALOX12B/15B. Our genetic findings thus provide evidence for immunoediting in tumors and uncover mechanisms of tumor-intrinsic resistance to cytolytic activity.

摘要

肿瘤的基因组格局如何塑造抗肿瘤免疫以及如何被抗肿瘤免疫塑造,尚未得到系统研究。利用实体组织肿瘤活检的大规模基因组数据集,我们量化了局部免疫浸润的细胞溶解活性,并确定了18种肿瘤类型的相关特征。预测的与MHC I类相关的新抗原数量与细胞溶解活性相关,在结直肠癌和其他肿瘤中低于预期,提示免疫介导的清除作用。我们鉴定出与细胞溶解活性呈正相关的反复突变基因,包括β2微球蛋白(B2M)、HLA-A、-B和-C以及半胱天冬酶8(CASP8),突出了抗原呈递缺失和外源性凋亡阻断作为抵抗细胞溶解活性的关键策略。基因扩增也与高细胞溶解活性相关,包括免疫抑制因子如PDL1/2和ALOX12B/15B。因此,我们的遗传学发现为肿瘤中的免疫编辑提供了证据,并揭示了肿瘤内在抵抗细胞溶解活性的机制。

相似文献

1
Molecular and genetic properties of tumors associated with local immune cytolytic activity.
Cell. 2015 Jan 15;160(1-2):48-61. doi: 10.1016/j.cell.2014.12.033.
2
Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer.
Clin Cancer Res. 2017 Jun 15;23(12):3129-3138. doi: 10.1158/1078-0432.CCR-16-2128. Epub 2016 Dec 22.
4
NLRC5/MHC class I transactivator is a target for immune evasion in cancer.
Proc Natl Acad Sci U S A. 2016 May 24;113(21):5999-6004. doi: 10.1073/pnas.1602069113. Epub 2016 May 9.
5
MHC class I antigens, immune surveillance, and tumor immune escape.
J Cell Physiol. 2003 Jun;195(3):346-55. doi: 10.1002/jcp.10290.
6
Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity.
Eur J Immunol. 2005 Sep;35(9):2518-27. doi: 10.1002/eji.200535002.

引用本文的文献

1
Adaptive individualized gene pair signatures distinguishing melanoma and predicting response to immune checkpoint blockade.
iScience. 2025 Aug 8;28(9):113329. doi: 10.1016/j.isci.2025.113329. eCollection 2025 Sep 19.
2
SLAMF7 (CD319) enhances cytotoxic T-cell differentiation and sensitizes CD8 T cells to immune checkpoint blockade.
Front Immunol. 2025 Aug 20;16:1654374. doi: 10.3389/fimmu.2025.1654374. eCollection 2025.
7
Patient-derived colorectal microtumors predict response to anti-PD-1 therapy.
Front Immunol. 2025 Aug 12;16:1640500. doi: 10.3389/fimmu.2025.1640500. eCollection 2025.
8
Is neoadjuvant immunotherapy feasible for patients with dMMR/MSI-H locally advanced colorectal cancer? a retrospective study.
Front Immunol. 2025 Aug 12;16:1645412. doi: 10.3389/fimmu.2025.1645412. eCollection 2025.
9
Mutational landscape of triple-negative breast cancer in African American women.
Nat Genet. 2025 Aug 26. doi: 10.1038/s41588-025-02322-y.

本文引用的文献

1
PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Nature. 2014 Nov 27;515(7528):568-71. doi: 10.1038/nature13954.
2
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.
Nature. 2014 Nov 27;515(7528):563-7. doi: 10.1038/nature14011.
3
Genetic basis for clinical response to CTLA-4 blockade in melanoma.
N Engl J Med. 2014 Dec 4;371(23):2189-2199. doi: 10.1056/NEJMoa1406498. Epub 2014 Nov 19.
4
Personal neoantigen cancer vaccines: The momentum builds.
Oncoimmunology. 2014 Jun 25;3:e29311. doi: 10.4161/onci.29311. eCollection 2014.
5
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 2014 Sep 11;513(7517):202-9. doi: 10.1038/nature13480. Epub 2014 Jul 23.
6
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia.
Blood. 2014 Jul 17;124(3):453-62. doi: 10.1182/blood-2014-04-567933. Epub 2014 Jun 2.
7
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival.
Genome Res. 2014 May;24(5):743-50. doi: 10.1101/gr.165985.113. Epub 2014 Apr 29.
9
A promoter-level mammalian expression atlas.
Nature. 2014 Mar 27;507(7493):462-70. doi: 10.1038/nature13182.
10
Discovery and saturation analysis of cancer genes across 21 tumour types.
Nature. 2014 Jan 23;505(7484):495-501. doi: 10.1038/nature12912. Epub 2014 Jan 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验